Analysts Anticipate RXi Pharmaceuticals Corp. (RXII) to Announce ($0.23) Earnings Per Share


Shares of RXi Pharmaceuticals Corp. have received a consensus broker rating score of 1.00 from the two brokers that provide coverage for the company, Zacks Investment Research reports. Two equities research analysts have rated the stock with a strong buy recommendation.



from Biotech News